Sign in
Menu
Sign in

Saxagliptin Powder Factory Supply

3 year ago
103 0
Video details
Saxagliptin is a type 2 diabetes medication that stimulates the pancreas to produce more insulin after meals. It was jointly developed by AstraZeneca and Bristol-Myers Squibb. It is a dipeptidyl peptidase-4 (DPP-IV) inhibitor. On July 31, 2009, AstraZeneca and Bristol-Myers Squibb jointly developed a new type 2 diabetes drug, saxagliptin (Onglyza), which was approved by the US FDA for listing once a day to treat adult type 2 diabetes while controlling diet, exercise. The most common side effects were upper respiratory tract infection, urinary tract infection and headache, other side effects included allergic-like reactions such as rash and hives. Mechanism of Action Saxagliptin works by blocking the degradation of GLP-1, a hormone naturally produced in the intestine after ingestion of food that regulates insulin secretion and enhances the availability of glucose in surrounding tissues . Saxagliptin alone can improve blood sugar control, and the combination with metformin, sulfonylureas, and thiazolidinediones can enhance the efficacy, and its risk of causing hypoglycemia is less, and the adverse reactions are similar to placebo, showing better results. tolerance.
Bossgoovideo.com Contact Now

If you are interested in the product, contact Bossgoovideo.com for more information

*To:
Xi'an Henrikang Biotech Co.,Ltd
*Message:
Submit
Disclaimer :
The information of Bossgoovideo.com limited shown above is provided by the user or collected on the network. Video 2B does not guarantee the authenticity,accuracy and legitimacy of Bossgoovideo.com limited information. Video 2B does not involve legal relationships and disputes between users arising from transactions other than secured transactions on this website. Disputes shall be settled by you through negotiation. If you are the person in charge or relevant employee of this enterprise, if you find that the enterprise information is incorrect or want to manage thiscompany, please contact us jacklee1558@gmail.com, after you claim the enterprise, you can obtain management permission, publish supplyand demand information, bring consulting orders, and remove page advertisements.